既存の病院用分析装置で偽ワクチンを低コスト検出可能(Existing hospital analysers offer a low-cost method to screen for fake vaccines)

ad

2026-02-17 オックスフォード大学

オックスフォード大学の研究チームは、既存の病院用分析装置を活用して偽造ワクチンを低コストで迅速に識別できる手法を開発した。特別な新規機器を導入せず、広く普及している分析プラットフォームのデータを解析することで、有効成分や成分組成の異常を検出できることを実証。供給網が脆弱な地域でも導入可能で、公衆衛生上の大きな脅威である偽造医薬品対策に貢献する。既存インフラを活かす点で実装性が高く、世界的なワクチン安全確保の強化につながる成果とされる。

<関連情報>

生化学プロファイリングは、偽造ワクチンやインスリンを検出するための低コストで世界的に利用可能な方法を提供します Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin

Jennifer Brook,Tehmina Bharucha,Benediktus Yohan Arman,Céline Caillet,Susan Morris,Michelle Taylor-Siddons,Laura Gomez Fernandez,John Walsby-Tickle,Isabelle Legge,Sneha Banerjee,Michael Deats,Rajender Jena,Dnyanesh S. Ranade,Shrikrishna R. Chunekar,Kundan D. Patil,Sunil Gairola,Susanna Dunachie,Hamid A. Merchant,Robert Stokes,Rutendo Kuwana,Alexandrine Maes,Sarah Gilbert,James McCullagh,Pavel Matousek,… Tim James
Scientific Reports  Published:16 February 2026
DOI:https://doi.org/10.1038/s41598-026-37281-9

既存の病院用分析装置で偽ワクチンを低コスト検出可能(Existing hospital analysers offer a low-cost method to screen for fake vaccines)

Abstract

For many decades, there have been numerous reported cases of falsified liquid medical products, including vaccine and insulin preparations worldwide, but to date, there has been a lack of affordable and accessible analytical methods for biological medicines and vaccine authenticity testing. A conventional clinical chemistry analyser (Abbott Architect c16000) was used to determine the concentrations of analytes in genuine liquid biological products (vaccines and insulin) and falsified vaccine surrogates. Eight analytes were measured for each sample: sodium, potassium, chloride, calcium, magnesium, phosphate, glucose and protein. Each genuine liquid product had unique concentrations of analytes when tested using the eight methods applied, allowing clear differentiation from the falsified surrogates. In a blinded study, reproducibility was significantly high when the samples were run intra- and inter-batch up to 9 times over 9 different days, and it was possible to identify most of the samples by analyte presence alone. Imprecision was < 1.0 CV% for ion-selective electrode methods and typically < 5 CV% for spectrophotometric methods. A decision tree was created which was able to identify all samples. We demonstrate for the first time that a conventional clinical chemistry analyser provides a low-cost method to accurately differentiate genuine products from falsified surrogate liquid medicines and vaccines. This novel method has the potential to be used globally due to widespread use of clinical chemistry analysers in hospitals across the world, including in low- and middle-income countries where many cases of falsified medicines have been identified.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました